1. Home
  2. SONM vs NERV Comparison

SONM vs NERV Comparison

Compare SONM & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONM
  • NERV
  • Stock Information
  • Founded
  • SONM 1999
  • NERV 2007
  • Country
  • SONM United States
  • NERV United States
  • Employees
  • SONM N/A
  • NERV N/A
  • Industry
  • SONM Telecommunications Equipment
  • NERV Biotechnology: Pharmaceutical Preparations
  • Sector
  • SONM Telecommunications
  • NERV Health Care
  • Exchange
  • SONM Nasdaq
  • NERV Nasdaq
  • Market Cap
  • SONM 17.8M
  • NERV 18.3M
  • IPO Year
  • SONM 2019
  • NERV 2014
  • Fundamental
  • Price
  • SONM $3.35
  • NERV $2.19
  • Analyst Decision
  • SONM
  • NERV Hold
  • Analyst Count
  • SONM 0
  • NERV 1
  • Target Price
  • SONM N/A
  • NERV $5.00
  • AVG Volume (30 Days)
  • SONM 31.2K
  • NERV 14.3K
  • Earning Date
  • SONM 11-13-2024
  • NERV 11-05-2024
  • Dividend Yield
  • SONM N/A
  • NERV N/A
  • EPS Growth
  • SONM N/A
  • NERV N/A
  • EPS
  • SONM N/A
  • NERV N/A
  • Revenue
  • SONM $56,744,000.00
  • NERV N/A
  • Revenue This Year
  • SONM N/A
  • NERV N/A
  • Revenue Next Year
  • SONM $107.78
  • NERV N/A
  • P/E Ratio
  • SONM N/A
  • NERV N/A
  • Revenue Growth
  • SONM N/A
  • NERV N/A
  • 52 Week Low
  • SONM $2.32
  • NERV $2.06
  • 52 Week High
  • SONM $10.70
  • NERV $13.49
  • Technical
  • Relative Strength Index (RSI)
  • SONM 48.21
  • NERV 45.26
  • Support Level
  • SONM $3.16
  • NERV $2.08
  • Resistance Level
  • SONM $3.99
  • NERV $2.32
  • Average True Range (ATR)
  • SONM 0.37
  • NERV 0.13
  • MACD
  • SONM 0.02
  • NERV 0.01
  • Stochastic Oscillator
  • SONM 41.55
  • NERV 33.33

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the United States, and to Bell, Rogers, and Telus Mobility in Canada. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

Share on Social Networks: